Stellantis (STLA IM/ STLA FP) CEO says sees improvments in H1 in all its key metrics; on a trajectory for a gradual and progressive recovery
Newsquawk Staff ·
Stellantis (STLA IM/ STLA FP) CEO says sees improvments in H1 in all its key metrics; on a trajectory for a gradual and progressive recovery.
What it means
Recovery language of this kind from a new or reshuffled management team follows a familiar pattern in autos: the first cycle of commentary after a downturn is usually framed around sequential improvement rather than absolute levels, and the market's response has historically depended on whether the claims can be tied to hard line items such as industrial free cash flow, operating margins, and dealer inventory normalization rather than to adjectives. Stellantis enters such episodes with a specific credibility ledger, having previously warned on profit and reset expectations, so incremental upbeat commentary tends to be discounted until confirmed in a print. The distinction worth drawing is between volume recovery and price/mix recovery: the former is visible early in shipments and registrations, the latter shows up only in margins and is where prior guidance resets in the sector have been earned back or lost. Worth noting is the follow-on sequence typical here, with commentary of this sort usually preceding a capital markets update or formal guidance restatement, and the peer set trading partly as a read-through on European and North American pricing discipline. As management commentary rather than a scheduled release, it moves the stock at the margin; the numbers remain the arbiter.
- Instacart (CART) is reportedly exploring a sale, The Information reports; held talks with DoorDash (DASH) and Uber (UBER)
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans
Related headlines
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL4 hours ago
- Moonshot AI unveils 2.8tln-parameter Kimi K3.1 Pro model; says it beats Opus 5.5 and GPT-6 Astra on long-horizon coding tasks and scores top marks on SWE Marathon and agent benchmarks; pledges open weights for the 3tln-class model by November 4th5 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS6 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 20276 hours ago
- OpenAI reveals plans for an in-house exabyte-scale storage system6 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter6 hours ago
- Upside in Penguin Solutions (PEGN) attributed to M&A chatter - UNCONFIRMED 6 hours ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability7 hours ago
- US President Trump says Elon Musk will not do anything wrong regarding access to Starlink (SPCX) in Ukraine7 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)7 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed7 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce8 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders9 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer9 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation9 hours ago